(Q37317112)

19 August 2017

Type 1 plasminogen activator inhibitor as a common risk factor for cancer and ischaemic vascular disease: the EPICOR study (English)

1 reference

19 August 2017

0 references

1 reference

1 reference

6

1 reference

19 August 2017

13

1 reference

19 August 2017

Amalia De Curtis

3

0 references

Claudia Agnoli

Claudia Agnoli

2

0 references

Giuseppe Matullo

Giuseppe Matullo

8

0 references

Amalia Mattiello

Amalia Mattiello

7

0 references

Carlotta Sacerdote

Carlotta Sacerdote

9

0 references

Licia Iacoviello

Licia Iacoviello

1

0 references

Maria Benedetta Donati

Maria Benedetta Donati

14

0 references

Rosario Tumino

10

Rosario Tumino

1 reference

19 August 2017

11

Paolo Vineis

1 reference

19 August 2017

Augusto Di Castelnuovo

4

Augusto di Castelnuovo

1 reference

Maria Concetta Giurdanella

19 August 2017

5

Maria Concetta Giurdanella

1 reference

19 August 2017

Giovanni de Gaetano

12

1 reference

19 August 2017

14 November 2013

1 reference

19 August 2017

1 reference

19 August 2017

3

1 reference

19 August 2017

11

1 reference

19 August 2017

e003725

1 reference

Obesity and risk of colorectal cancer: a systematic review of prospective studies

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831102

Growth hormone, the insulin-like growth factor axis, insulin and cancer risk.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831102

Plasminogen activator inhibitor-1 is an aggregate response factor with pleiotropic effects on cell signaling in vascular disease and the tumor microenvironment

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831102

Nutrigenomics: a case for the common soil between cardiovascular disease and cancer

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831102

Host plasminogen activator inhibitor-1 promotes human skin carcinoma progression in a stage-dependent manner.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831102

Diet in the Italian EPIC cohorts: presentation of data and methodological issues.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831102

The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831102

Elements of the fibrinolytic system

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831102

The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831102

The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831102

Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831102

The pathogenesis of atherosclerosis: a perspective for the 1990s

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831102

Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831102

The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831102

Elaboration of type-1 plasminogen activator inhibitor from adipocytes. A potential pathogenetic link between obesity and cardiovascular disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831102

Comparison with manual registration reveals satisfactory completeness and efficiency of a computerized cancer registration system

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831102

Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831102

The adipocyte and hemostatic balance in obesity: studies of PAI-1.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831102

Long-term stability of fibrinolytic factors stored at -80 degrees C.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831102

A molecular epidemiology project on diet and cancer: the EPIC-Italy Prospective Study. Design and baseline characteristics of participants.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831102

High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831102

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831102

Fibrin D-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and the risk of major ischaemic heart disease in the Caerphilly Study.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831102

The MET oncogene drives a genetic programme linking cancer to haemostasis

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831102

The "common soil hypothesis": evidence from population studies?

3 December 2018

1 reference

12 December 2020

The 4G/5G polymorphism of PAI-1 promoter gene and the risk of myocardial infarction: a meta-analysis

1 reference

12 December 2020

Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer

1 reference

12 December 2020

Expression of plasminogen activator inhibitors type 1 and type 3 and urokinase plasminogen activator protein and mRNA in breast cancer

1 reference

12 December 2020

PAI-1, obesity, insulin resistance and risk of cardiovascular events

1 reference

12 December 2020

The case-cohort design in outbreak investigations

1 reference

12 December 2020

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

1 reference

12 December 2020

Universal definition of myocardial infarction

1 reference

12 December 2020

Intra-individual variation of plasma adipokine levels and utility of single measurement of these biomarkers in population-based studies

1 reference

12 December 2020

The prognostic value of vascular endothelial growth factor, urokinase plasminogen activator and plasminogen activator inhibitor-1 in node-negative breast cancer

1 reference

12 December 2020

Long-term follow-up confirms prognostic impact of PAI-1 and cathepsin D and L in primary breast cancer

1 reference

12 December 2020

Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study

1 reference

12 December 2020

STANDARDISATION OF OBSERVERS IN BLOOD-PRESSURE MEASUREMENT

1 reference

12 December 2020

Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis.

1 reference

12 December 2020

Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke

1 reference

12 December 2020

10.1136/BMJOPEN-2013-003725

Identifiers

DOI

1 reference

release_uentavbpgrdhxfoxwwjkatj5ua

19 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uentavbpgrdhxfoxwwjkatj5ua

24 November 2022

mapped directly with Wikidata item

1 reference

19 August 2017

PubMed publication ID

24231461

1 reference